HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options

This article was originally published in The Tan Sheet

Executive Summary

FDA attempts to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and details corresponding label requirements in draft guidance released Aug. 1

You may also be interested in...



EC Science Committee Gives Qualified OK For 4-MBC In Sunscreens

The European Commission's Scientific Committee on Consumer Products responds to data from the personal care product industry and decides that, at least temporarily, 4-methylbenzylidene camphor is safe in sunscreens at concentrations up to 4 percent

Environmental Group Scorches Most Sunscreens, Stresses Need For FDA Rule

The Environmental Working Group says its updated review of nearly 1,000 sunscreen products further demonstrates the need for updated FDA safety standards as consumers buy "products that could be completely inadequate for sun protection.

P&G Should Clean Up Vicks Early Defense Hand Sanitizer Claims, Labels – FDA

Product claims and labeling for Procter & Gamble's Vicks Early Defense Foaming Hand Sanitizer are not allowed under FDA's tentative final mono-graphs for OTC health care and first aid antiseptics, according to the agency

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel